Exercise can lengthen remission after being diagnosed with type 1 diabetes.
Read More »Aspirin No Longer Preventative Drug for Cardiovascular Disease
Increased risk of hemorrhage with no significant lowering of cardiovascular risk means low-dose aspirin recommendations are in peril.
Read More »Omega-3 Supplementation Fails to Prevent Heart Disease
No significant statistical differences found between patients with diabetes using supplement versus placebo.
Read More »How Ethnicity Can Influence the Risk of Type 1 Diabetes
Obesity found as additional impact in patients with multiple autoantibody positivity.
Read More »Lack of Sleep Slows Wound Healing in Patients with Type 2 Diabetes
Study shows mice with obesity and type 2 have significantly slower healing of wounds compared to those with undisturbed sleep.
Read More »WHO Guidelines Recommend Treatment Intensifications in Type 2 Diabetes
Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.
Read More »Poor Glycemic Management Equals Risk of Dementia
Patients with type 1 diabetes and prolonged increased HbA1c were found to be at two-times greater risk for dementia than those with well-managed HbA1c values.
Read More »Poor Understanding of Diabetes Therapy Leads to Increased Hba1c In Type 2 Diabetes
Thorough knowledge of anti-diabetes medications found to lead to better management, adherence.
Read More »Semaglutide May Foster Significant Weight Loss in Patients with Obesity
When combined with diet and exercise, GLP-1 medication showed significant weight loss compared to liraglutide and placebo, a new study finds.
Read More »GLP-1 Agonists Do Not Increase Risk for Diabetic Retinopathy
New findings compare treatment with patients taking two or more glucose-lowering agents.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.